Data / Form D filings / SpringLeaf Therapeutics, Inc.
SpringLeaf Therapeutics, Inc.: Form D filings
SpringLeaf Therapeutics, Inc., a pharmaceuticals company in Boston, MA, filed 2 Form D notices with the SEC in 2011. The latest, on July 8, 2011, reports $19 million sold of a $19 million offering to 8 investors.
Find out what SpringLeaf Therapeutics, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 8 ST. MARY'S STREET, SUITE 601, Boston, MA, 02215
- Phone
- (617) 358-4927
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2007
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1413681
The full lists. Form D filings in Massachusetts: 1,533 rows, $76.65, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 8, 2011 | Amendment | $19,047,501 | $19,047,501 | $0 | 8 | Apr 28, 2011 | sec.gov |
| May 12, 2011 | New notice | $15,037,500 | $15,037,500 | $0 | 6 | Apr 28, 2011 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Garen Bohlin | Director | |
| Glenn Larsen | Executive Officer | |
| Brian Gallagher | Director | |
| Kurt Graves | Director | |
| Michael Greeley | Director | |
| Frank Bobe | Executive Officer, Director | |
| Jeffrey McCarthy | Director | |
| Yet-Ming Chiang | Director | |
| Michael Cima | Director |
Other pharmaceuticals companies in Massachusetts that filed recently
- BridgeHealth Pharmaceuticals, Inc. $3.5 million · Nov 5, 2026
- Land Therapeutics Inc. $17.5 million · Oct 21, 2026
- Crosslink Therapeutics Inc. $5.5 million · Oct 20, 2026
- Sentonix, Inc. $12.7 million · Aug 20, 2026
Every Form D from the week of Jul 4, 2011 · All recent filings in Massachusetts · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what SpringLeaf Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.